• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Identification of oral risk factors for chronic graft versus host disease in haematological patients who underwent allogeneic haematopoietic stem cell transplantation.对接受异基因造血干细胞移植的血液病患者慢性移植物抗宿主病口腔危险因素的识别。
Oral Implantol (Rome). 2017 Jan 21;10(4):390-397. doi: 10.11138/orl/2017.10.4.390. eCollection 2017 Oct-Dec.
2
Mesenchymal stromal cells as treatment or prophylaxis for acute or chronic graft-versus-host disease in haematopoietic stem cell transplant (HSCT) recipients with a haematological condition.间充质基质细胞作为患有血液疾病的造血干细胞移植(HSCT)受者急性或慢性移植物抗宿主病的治疗或预防手段。
Cochrane Database Syst Rev. 2019 Jan 30;1(1):CD009768. doi: 10.1002/14651858.CD009768.pub2.
3
Clinical and histopathological features of the oral mucosa in allogeneic haematopoietic stem cell transplantation patients.异基因造血干细胞移植患者口腔黏膜的临床和组织病理学特征
Exp Oncol. 2007 Dec;29(4):304-8.
4
Value of Autoantibody Expression During Long-Term Follow-Up in Paediatric ALL Patients After Allogeneic Haematopoietic Stem Cell Transplantation.异基因造血干细胞移植后小儿急性淋巴细胞白血病患者长期随访期间自身抗体表达的价值
Front Pediatr. 2021 Dec 21;9:788360. doi: 10.3389/fped.2021.788360. eCollection 2021.
5
A Review of Oral Chronic Graft-Versus-Host Disease: Considerations for dental hygiene practice.口腔慢性移植物抗宿主病综述:对口腔保健实践的考虑。
J Dent Hyg. 2022 Apr;96(2):6-17.
6
Impact of chronic graft-versus-host disease on quality of life and cognitive function of long-term transplant survivors after allogeneic hematopoietic stem cell transplantation with total body irradiation.全身照射异基因造血干细胞移植后慢性移植物抗宿主病对长期移植幸存者生活质量和认知功能的影响。
Radiat Oncol. 2022 Nov 29;17(1):195. doi: 10.1186/s13014-022-02161-9.
7
Ocular Chronic Graft-versus-Host Disease and Its Relation to Other Organ Manifestations and Outcomes after Allogeneic Hematopoietic Cell Transplantation.异基因造血细胞移植后眼慢性移植物抗宿主病及其与其他器官表现和结局的关系。
Transplant Cell Ther. 2022 Dec;28(12):833.e1-833.e7. doi: 10.1016/j.jtct.2022.08.016. Epub 2022 Aug 22.
8
Chronic graft-versus-host disease of the kidney in patients with allogenic hematopoietic stem cell transplant.同种异体造血干细胞移植后患者的慢性移植物抗宿主病的肾脏表现。
Eur J Haematol. 2013 Aug;91(2):129-34. doi: 10.1111/ejh.12149. Epub 2013 Jun 28.
9
Chronic Graft Versus Host Disease in Acute Leukemia Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplant: Analysis of Risk Factors, Pattern and Long Term Outcome.接受异基因造血干细胞移植的急性白血病患者的慢性移植物抗宿主病:危险因素、模式及长期结局分析
Indian J Hematol Blood Transfus. 2016 Mar;32(1):32-8. doi: 10.1007/s12288-015-0506-5. Epub 2015 Jan 20.
10
Polyclonal anti-thymocyte globulins for the prophylaxis of graft-versus-host disease after allogeneic stem cell or bone marrow transplantation in adults.多克隆抗胸腺细胞球蛋白用于预防成人异基因干细胞或骨髓移植后的移植物抗宿主病。
Cochrane Database Syst Rev. 2012 Sep 12(9):CD009159. doi: 10.1002/14651858.CD009159.pub2.

引用本文的文献

1
Comparison of oral chronic graft-versus-host disease characteristics between patients with malignant and non-malignant hematopoietic disorders.恶性与非恶性造血系统疾病患者口腔慢性移植物抗宿主病特征的比较
BMC Oral Health. 2025 Mar 28;25(1):449. doi: 10.1186/s12903-025-05785-x.

本文引用的文献

1
The Rome Transplant Network model compared to the Italian Bone Marrow Donor Registry activity for unrelated donor search process and transplant efficiency for hematologic malignancy.将罗马移植网络模型与意大利骨髓捐献者登记处寻找非亲属捐献者的活动以及血液系统恶性肿瘤的移植效率进行比较。
Transfusion. 2017 Jul;57(7):1734-1743. doi: 10.1111/trf.14131. Epub 2017 Jun 13.
2
Haploidentical, G-CSF-primed, unmanipulated bone marrow transplantation for patients with high-risk hematological malignancies: an update.单倍体相合、粒细胞集落刺激因子动员、未处理的骨髓移植治疗高危血液系统恶性肿瘤患者:最新进展
Bone Marrow Transplant. 2015 Jun;50 Suppl 2:S24-30. doi: 10.1038/bmt.2015.91.
3
Comparison of outcomes after unrelated cord blood and unmanipulated haploidentical stem cell transplantation in adults with acute leukemia.成人急性白血病患者非亲缘脐带血与未经处理的单倍体相合造血干细胞移植后结局的比较。
Leukemia. 2015 Sep;29(9):1891-900. doi: 10.1038/leu.2015.98. Epub 2015 Apr 17.
4
National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: V. The 2014 Ancillary Therapy and Supportive Care Working Group Report.美国国立卫生研究院慢性移植物抗宿主病临床试验标准共识发展项目:五、2014年辅助治疗与支持性护理工作组报告
Biol Blood Marrow Transplant. 2015 Jul;21(7):1167-87. doi: 10.1016/j.bbmt.2015.03.024. Epub 2015 Mar 31.
5
National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group report.美国国立卫生研究院慢性移植物抗宿主病临床试验标准共识发展项目:I. 2014年诊断与分期工作组报告
Biol Blood Marrow Transplant. 2015 Mar;21(3):389-401.e1. doi: 10.1016/j.bbmt.2014.12.001. Epub 2014 Dec 18.
6
Biological significance of HLA locus matching in unrelated donor bone marrow transplantation.无关供者骨髓移植中HLA位点匹配的生物学意义
Blood. 2015 Feb 12;125(7):1189-97. doi: 10.1182/blood-2014-10-604785. Epub 2014 Dec 17.
7
Allogeneic haematopoietic stem cell transplantation in myelodysplastic syndromes.异基因造血干细胞移植治疗骨髓增生异常综合征
Curr Opin Oncol. 2014 Nov;26(6):642-9. doi: 10.1097/CCO.0000000000000137.
8
Fibrin glue therapy for severe hemorrhagic cystitis after allogeneic hematopoietic stem cell transplantation.纤维蛋白胶治疗异基因造血干细胞移植后严重出血性膀胱炎
Biol Blood Marrow Transplant. 2014 Oct;20(10):1612-7. doi: 10.1016/j.bbmt.2014.06.018. Epub 2014 Jun 20.
9
Umbilical cord blood transplantation from unrelated donors in patients with Philadelphia chromosome-positive acute lymphoblastic leukemia.Ph 染色体阳性急性淋巴细胞白血病患者接受无关供者脐带血移植。
Haematologica. 2014 Feb;99(2):378-84. doi: 10.3324/haematol.2013.091009. Epub 2013 Oct 4.
10
Impact of HLA mismatch direction on outcomes after umbilical cord blood transplantation for hematological malignant disorders: a retrospective Eurocord-EBMT analysis.人类白细胞抗原错配方向对血液系统恶性疾病脐带血移植后结局的影响:一项欧洲脐带血库-欧洲血液与骨髓移植协会的回顾性分析
Bone Marrow Transplant. 2014 Jan;49(1):24-9. doi: 10.1038/bmt.2013.120. Epub 2013 Aug 19.

对接受异基因造血干细胞移植的血液病患者慢性移植物抗宿主病口腔危险因素的识别。

Identification of oral risk factors for chronic graft versus host disease in haematological patients who underwent allogeneic haematopoietic stem cell transplantation.

作者信息

Picardi A, Miranda M, Liciani F, Paterno G, Arcese W, Bollero P

机构信息

Stem Cell Transplant Unit, Hematology, Department of Biomedicine and Prevention, University of Rome "Tor Vergata", Rome, Italy.

Oral Pathology, Department of Systems Medicine, University of Rome "Tor Vergata", Rome, Italy.

出版信息

Oral Implantol (Rome). 2017 Jan 21;10(4):390-397. doi: 10.11138/orl/2017.10.4.390. eCollection 2017 Oct-Dec.

DOI:10.11138/orl/2017.10.4.390
PMID:29682256
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5892662/
Abstract

OBJECTIVE

The aim of this prospective observational study was to identify local risk factors for the development of clinical manifestations of oral chronic Graft versus Host Disease (cGvHD) in a cohort of patients affected by haematological malignant diseases who underwent allogeneic haematopoietic stem cell transplantation (HSCT).

MATERIALS AND METHODS

In the context of an active collaboration between the Rome Transplant Network of the Hematology and the Oral Pathology Division at "Policlinico Tor Vergata", in Rome, 47 haematological patients were included in this trial based on a systematic dental screening and follow-up protocol. The dental checks were planned 1 month before the transplant procedure while the subsequent follow ups were scheduled on day +100, +180, +365 and + 730 after the transplant. The tool used for the dental checks was a detailed report including all the potential oral features responsible of mechanical, chemical or infective injuries, except for the drugs.

RESULTS

Overall, 64% of patients (N=30) did not perform dental hygiene during the screening pre-transplant and 53% (25/47) developed cGvHD with oral involvement. The most part of patients (84%) who experienced oral manifestations of cGvHD during the follow-up period after HSCT did not perform dental hygiene before the transplant procedure. Moreover, the comparison between the "presence" or "absence" of dental hygiene before the allogeneic HSCT showed a statistical significant increasing during the follow-up period in the occurrence of oral lesions due to the cGvHD for patients who lack pre-transplant dental care (p=0.029).On the contrary, the frequency of the other factors such as malocclusions, fractured teeth, incongruous prosthesis, food, smoke, alcol and bad habits, resulted similar between the group with or without typical oral lesions of cGvHD.

CONCLUSIONS

The prevention of oral infectious complications provided by primary and secondary dental cares can result in a great benefit for haematological patients who underwent allogeneic HSCT. The combined hematological and dental management represents a clinical need before and after allogeneic HSCT for the removal of inconvenient issues with impact on the short and long-term outcome. Poor dental hygiene seems to be a local risk factor for the development of oral lesions due to cGvHD. However, a larger cohort of patients is necessary to confirm these preliminary data and to evaluate the best preventive and therapeutic oral hygiene protocol in this specific setting.

摘要

目的

这项前瞻性观察性研究的目的是在一组接受异基因造血干细胞移植(HSCT)的血液系统恶性疾病患者中,确定口腔慢性移植物抗宿主病(cGvHD)临床表现发展的局部危险因素。

材料和方法

在罗马“托尔韦尔加塔大学综合医院”血液学的罗马移植网络与口腔病理学部门的积极合作背景下,根据系统的牙科筛查和随访方案,47例血液学患者被纳入该试验。牙科检查计划在移植手术前1个月进行,随后的随访安排在移植后的第100天、第180天、第365天和第730天。用于牙科检查的工具是一份详细报告,包括除药物外所有可能导致机械性、化学性或感染性损伤的口腔特征。

结果

总体而言,64%的患者(N = 30)在移植前筛查期间未进行口腔卫生护理,53%(25/47)的患者发生了伴有口腔受累的cGvHD。在HSCT后的随访期间出现cGvHD口腔表现的大多数患者(84%)在移植手术前未进行口腔卫生护理。此外,对异基因HSCT前“有”或“无”口腔卫生护理情况的比较显示,对于缺乏移植前牙科护理的患者,随访期间因cGvHD出现口腔病变的发生率有统计学意义的增加(p = 0.029)。相反,诸如错牙合、牙齿折断、假体不合适以及食物、吸烟、酒精和不良习惯等其他因素的频率,在有或无cGvHD典型口腔病变的组之间相似。

结论

一级和二级牙科护理所提供的口腔感染并发症预防措施,对接受异基因HSCT的血液学患者可能带来很大益处。血液学和牙科的联合管理是异基因HSCT前后的临床需求,以消除对短期和长期结果有影响的不便问题。口腔卫生差似乎是cGvHD导致口腔病变发展的一个局部危险因素。然而,需要更大规模的患者队列来证实这些初步数据,并评估在这种特定情况下最佳的预防性和治疗性口腔卫生方案。